Answer
Acute leukaemia and bone-marrow dysplasia have been reported after long-term systemic exposure. The treating team weighs this delayed risk against the expected treatment benefit.
Sources for this answer
- Carmustine Waymade 100 mg powder and solvent for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.